Ascend Wellness Holdings (AAWH) Change in Receivables (2020 - 2026)
Ascend Wellness Holdings' (AAWH) quarterly Change in Receivables came in at -$601000.0 in Q1 2026, down 437.64% year-on-year from $178000.0 in Q1 2025, and up 67.01% quarter-over-quarter from -$1.8 million in Q4 2025.
Ascend Wellness Holdings (AAWH) Change in Receivables (2020 - 2026) Analysis & Trends
Ascend Wellness Holdings' Change in Receivables history runs 7 years deep, the most recent figure standing at -$601000.0 for Q1 2026.
- On a quarterly basis, Change in Receivables fell 437.64% year-over-year to -$601000.0 in Q1 2026; TTM through Mar 2026 was -$8.7 million, a 1158.27% decrease from a year earlier, with the FY2025 full-year figure at -$7.9 million, down 196.07% from the prior year.
- Change in Receivables advanced to -$601000.0 in Q1 2026 per AAWH's latest filing, from -$1.8 million in the prior quarter.
- Across five years, Change in Receivables topped out at $7.6 million in Q1 2024 and bottomed at -$6.1 million in Q2 2025.
- The 5-year median for Change in Receivables is $714000.0 (2022), against an average of $1.2 million.
- Across the five-year window, Change in Receivables jumped 320.5% in 2023 and tumbled 940.17% in 2025, its largest moves.
- Year by year, Change in Receivables stood at $714000.0 in 2022, then jumped by 308.82% to $2.9 million in 2023, then tumbled by 176.5% to -$2.2 million in 2024, then increased by 18.41% to -$1.8 million in 2025, then soared by 67.01% to -$601000.0 in 2026.
- Per Business Quant, the three latest AAWH Change in Receivables figures stand at -$601000.0 (Q1 2026), -$1.8 million (Q4 2025), and -$191000.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | -78.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 106.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -621.82 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | -38.20 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 126.30 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 81.40 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Ascend Wellness Holdings | 83.00 Mn | 22.91 Mn | 44.88 Mn | -601,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -601,000.00 |
| Mar 31, 2026 | -601,000.00 |
| Dec 31, 2025 | -1.82 Mn |
| Dec 31, 2025 | -1.82 Mn |
| Sep 30, 2025 | -191,000.00 |
| Sep 30, 2025 | -191,000.00 |
| Jun 30, 2025 | -6.09 Mn |
| Jun 30, 2025 | -6.09 Mn |
| Mar 31, 2025 | 178,000.00 |
| Mar 31, 2025 | 178,000.00 |
| Dec 31, 2024 | -2.23 Mn |
| Dec 31, 2024 | -2.23 Mn |
| Sep 30, 2024 | 3.46 Mn |
| Sep 30, 2024 | 3.46 Mn |
| Jun 30, 2024 | -585,000.00 |
| Jun 30, 2024 | -585,000.00 |
| Mar 31, 2024 | 7.60 Mn |
| Mar 31, 2024 | 7.60 Mn |
| Dec 31, 2023 | 2.92 Mn |
| Dec 31, 2023 | 2.92 Mn |